Clinical trials are research studies involving volunteer patients to evaluate a treatment. These trials aim to determine the proper dosage and frequency, assess the treatment’s safety and effectiveness, and identify whether any side effects are manageable. The development of a new treatment is a lengthy process, typically taking five to seven years. Every step is closely regulated by the Food and Drug Administration (FDA).
For additional information on clinical trials visit:
Establishes the safe dosage of a treatment.
Evaluates safety, side effects, and effectiveness.
Assesses effectiveness and safety in a larger group of patients.
For rare disease treatments, the FDA often permits combining the first two phases of clinical trials due to the limited number of patients.
The best way to determine eligibility for a clinical trial is to connect with the study investigator. They can explain the study’s goals, participation requirements, and potential risks and benefits. Before proceeding with further screenings, assessments, or treatments, ensure that you sign an informed consent form.
For most clinical trials focused on rare diseases like Niemann-Pick Disease, there are no costs to participate. Treatments, hospital stays, and assessments are typically provided free of charge. In many cases, the trial may also cover travel, accommodations, and meals for the patient, as well as for a companion or caregiver.
To find clinical trials for Niemann-Pick Disease, visit clinicaltrials.gov. This site lists most U.S. based trials, along with details about eligibility and participation requirements.
We will continue to update information about clinical trials for Niemann-Pick Disease as new opportunities become available.
See the clinical trials and research studies for NPC and ASMD that are recruiting now, plus studies that are no longer enrolling.
Become an NNPDF member for the latest research updates, event invitations, and a direct line to the community.
